Trends in post–heart transplant biopsies for graft rejection versus nonrejection.
With alternatives such as gene profiling available for surveillance after orthotopic heart transplantation, we sought to evaluate the utilization of endomyocardial biopsies (EMBs) for hospitalized patients after heart transplantation. Surveillance EMBs in patients with and without complications were...
| Publicado en: | Baylor University Medical Center Proceedings Vol. 34; no. 3; pp. 345 - 349 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
Jul2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150005636&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 150005636 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08998280 1XEP jtl: Baylor University Medical Center Proceedings issn: 08998280 maglogo: N pubinfo: dt: Jul2021 vid: 34 iid: 3 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 150005636 148351753 150005636 150005636 10.1080/08998280.2021.1873032 150005636 ppf: 345 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Trends in post–heart transplant biopsies for graft rejection versus nonrejection. aug: au: Jamil, Aayla K. Afzal, Aasim Nisar, Tariq Kluger, Aaron Y. Felius, Joost Wencker, Detlef Hall, Shelley A. Kale, Parag affil: Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas sug: subj: Heart Transplantation Rehabilitation Biopsy Trends Graft Rejection Human Length of Stay Surgical Patients Descriptive Statistics Cost Benefit Analysis COVID-19 Pandemic ab: With alternatives such as gene profiling available for surveillance after orthotopic heart transplantation, we sought to evaluate the utilization of endomyocardial biopsies (EMBs) for hospitalized patients after heart transplantation. Surveillance EMBs in patients with and without complications were evaluated from the 2004 to 2014 National Inpatient Sample. Over the study period, there was no significant change in the number of EMB procedures performed (P = 0.44). Of 37,955 EMBs, 2283 (6%) were in the setting of graft complications, while 35,672 EMBs were not related to graft complications. EMBs in graft complications did not show a significant increase in length of stay over time (P = 0.06), but had a significant increase in cost over time (P = 0.001). However, those with graft complications had an average of a 5-day longer length of stay (P < 0.001) and costs that were $88,816 (P < 0.001) more expensive compared with those without graft complications. In conclusion, the vast majority of in-hospital EMBs were not related to heart transplantation complications. Nevertheless, EMB hospitalizations with graft complications showed significantly greater length of stay and cost. With the COVID-19 pandemic, it seems more effective to use minimal-contact health surveillance methods rather than invasive EMBs. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|